Categories Analysis, Retail

What to expect when Home Depot (HD) reports Q4 2023 earnings results

The consensus estimate for EPS in Q4 2023 is $2.76

Shares of the Home Depot (NYSE: HD) were down over 1% on Tuesday. The stock has gained 18% over the past three months. The home improvement retailer is scheduled to report its fourth quarter 2023 earnings results on Tuesday, February 20, before market open. Here’s a look at what to expect from the earnings report:

Revenue

Analysts are projecting revenues of $34.6 billion for the fourth quarter of 2023, which would imply a decrease of 3% from the same quarter a year ago. In the third quarter of 2023, revenues declined 3% year-over-year to $37.7 billion.

Earnings

The consensus estimate for EPS in Q4 2023 is $2.76, which compares to EPS of $3.30 in the prior-year quarter. In Q3 2023, EPS fell 10% to $2.81.

Points to note

Home Depot has been facing challenges such as slow demand in big-ticket, discretionary categories, and lumber and copper wire deflation. Customers have been opting for smaller projects over bigger renovations due to a tough economic environment. Despite this, the company has remained relatively resilient, providing optimism over its prospects.

The Pro customer segment has remained steady, outperforming the DIY customer segment. Although Pro backlogs appear to be lower than last year’s levels, they are still reportedly healthy and higher compared to historical norms. The stability in this segment is likely to benefit the results in the fourth quarter.

The investments that Home Depot is making in order to improve its product assortment, fulfillment and operations are also expected to benefit the company. Its efforts to enhance its digital capabilities are also expected to prove beneficial. Home Depot sees significant opportunity in the Pro market and it has been taking several steps to improve the shopping experience of its Pro customers. All this is expected to have a positive impact on its business performance.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top